scispace - formally typeset
Search or ask a question
Institution

Syngenta

CompanyBasel, Switzerland
About: Syngenta is a company organization based out in Basel, Switzerland. It is known for research contribution in the topics: Population & Gene. The organization has 4724 authors who have published 6036 publications receiving 164311 citations. The organization is also known as: Syngenta & Syngenta AG.
Topics: Population, Gene, Cultivar, Germplasm, Alkyl


Papers
More filters
Patent
24 Aug 2012
TL;DR: In this article, the present invention relates to compounds of formula (I) wherein P is selected from P1 and P2, or P and R 5 together are P3 or P is a heterocycle H, selected from H1 to H9 wherein Y 1, Y 2 and Y 3 are independently of each other C-H, C-R 5, or nitrogen.
Abstract: The present invention relates to compounds of formula (I) wherein P is selected from P1 and P2, or P and R 5 together are P3 or P is a heterocycle H, selected from H1 to H9 wherein Y 1 , Y 2 and Y 3 are independently of each other C-H, C-R 5 , or nitrogen; and G 1 , G 2 , G 3 ,Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 6b , R 7 , R 8 , R 9 , R 10 , R 11 , p, n and k are as defined in the claims. The invention also relates to methods of controlling insects, acarines, nematodes or molluscs which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I).

86 citations

Journal ArticleDOI
TL;DR: The definition of reporting guidelines for bioactive entities — the Minimum Information About a Bioactive Entity (MIABE) — which has been developed by representatives of pharmaceutical companies, data resource providers and academic groups are proposed.
Abstract: Bioactive molecules such as drugs, pesticides and food additives are produced in large numbers by many commercial and academic groups around the world. Enormous quantities of data are generated on the biological properties and quality of these molecules. Access to such data - both on licensed and commercially available compounds, and also on those that fail during development - is crucial for understanding how improved molecules could be developed. For example, computational analysis of aggregated data on molecules that are investigated in drug discovery programmes has led to a greater understanding of the properties of successful drugs. However, the information required to perform these analyses is rarely published, and when it is made available it is often missing crucial data or is in a format that is inappropriate for efficient data-mining. Here, we propose a solution: the definition of reporting guidelines for bioactive entities - the Minimum Information About a Bioactive Entity (MIABE) - which has been developed by representatives of pharmaceutical companies, data resource providers and academic groups.

85 citations

Journal ArticleDOI
TL;DR: It is concluded that honey bee pesticide risk assessments may not always be protective of bumble bees, especially queens, in terms of exposure.
Abstract: To date, regulatory pesticide risk assessments have relied on the honey bee (Apis mellifera L.) (Hymenoptera: Apidae) as a surrogate test species for estimating the risk of pesticide exposure to all bee species. However, honey bees and non-Apis bees may differ in their susceptibility and exposure to pesticides. In 2017, a workshop ('Pesticide Exposure Assessment Paradigm for Non-Apis Bees') was held to assess if honey bee risk assessment frameworks are reflective of non-Apis bee pesticide exposure. In this article, we summarize the workshop discussions on bumble bees (Bombus spp.). We review the life history and foraging behavior of bumble bees and honey bees and discuss how these traits may influence routes and levels of exposure for both taxa. Overall, the major pesticide exposure routes for bumble bees and honey bees are similar; however, bumble bees face additional exposure routes (direct exposure of foraging queens and exposure of larvae and adults to soil residues). Furthermore, bumble bees may receive comparatively higher pesticide doses via contact or oral exposure. We conclude that honey bee pesticide risk assessments may not always be protective of bumble bees, especially queens, in terms of exposure. Data needed to reliably quantify pesticide exposure for bumble bees (e.g., food consumption rates, soil residue levels) are lacking. Addressing these knowledge gaps will be crucial before bumble bee exposure can be incorporated into the pesticide risk assessment process. Because bumble bees exhibit appreciable interspecific variation in colony and behavioral characteristics, data relevant to pesticide exposure should be generated for multiple species.

85 citations

Journal ArticleDOI
TL;DR: Synthesis and multi-dimensional kinetic analysis of validoxylamine derivatives are used to access the 3-D structure of a ternary complex providing insight into the geometry and donor–acceptor interplay at the glycosyl transfer site.
Abstract: Structural “valid”-ation: The mechanism of enzyme-catalyzed glycosyl transfer with retention of anomeric configuration continues to baffle, a situation compounded by the lack of insightful 3-D structures of ternary enzyme complexes. Synthesis and multi-dimensional kinetic analysis of validoxylamine derivatives are used to access the 3-D structure of a ternary complex (see picture; U=uridyl) providing insight into the geometry and donor–acceptor interplay at the glycosyl transfer site.

85 citations

Journal ArticleDOI
TL;DR: This article summarizes the findings of a 2014 workshop held by the European Centre for Toxicology and Ecotoxicology of Chemicals and the UK Environment Agency in Amsterdam, The Netherlands on the ecological relevance, statistical basis, and regulatory applications of SSDs.
Abstract: A species sensitivity distribution (SSD) is a probability model of the variation of species sensitivities to a stressor, in particular chemical exposure. The SSD approach has been used as a decision support tool in environmental protection and management since the 1980s, and the ecotoxicological, statistical, and regulatory basis and applications continue to evolve. This article summarizes the findings of a 2014 workshop held by the European Centre for Toxicology and Ecotoxicology of Chemicals and the UK Environment Agency in Amsterdam, The Netherlands, on the ecological relevance, statistical basis, and regulatory applications of SSDs. An array of research recommendations categorized under the topical areas of use of SSDs, ecological considerations, guideline considerations, method development and validation, toxicity data, mechanistic understanding, and uncertainty were identified and prioritized. A rationale for the most critical research needs identified in the workshop is provided. The workshop reviewed the technical basis and historical development and application of SSDs, described approaches to estimating generic and scenario-specific SSD-based thresholds, evaluated utility and application of SSDs as diagnostic tools, and presented new statistical approaches to formulate SSDs. Collectively, these address many of the research needs to expand and improve their application. The highest priority work, from a pragmatic regulatory point of view, is to develop a guidance of best practices that could act as a basis for global harmonization and discussions regarding the SSD methodology and tools. Integr Environ Assess Manag 2017;13:664-674. © 2016 SETAC.

85 citations


Authors

Showing all 4737 results

NameH-indexPapersCitations
John R. Yates1771036129029
Thomas Boller10131042294
Tamio Hayashi9879935281
Ian Kimber9162028629
Roberto Bassi8932021655
Michael P. Washburn8129632468
Robert Gurny8139628391
Ian Jones8035337673
Xinnian Dong6610827849
Willem F. Broekaert6615519690
Rebecca J. Dearman6628713197
Steven J. Rothstein6616413804
Tong Zhu6412417310
John Ryals6311523451
Nicholas A. Buckley6241914283
Network Information
Related Institutions (5)
Novartis
50.5K papers, 1.9M citations

85% related

United States Environmental Protection Agency
26.9K papers, 1.1M citations

85% related

Merck & Co.
48K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

85% related

GlaxoSmithKline
21.1K papers, 1.1M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202218
2021272
2020277
2019260
2018275
2017250